PATENT LICENSE AGREEMENTPatent License Agreement • April 1st, 2019 • AzurRx BioPharma, Inc. • Pharmaceutical preparations • New York
THIS PATENT LICENSE AGREEMENT (this “Agreement”) is entered into effective as of the 27 day of March, 2019 (the “Effective Date”) by and between AzurRx BioPharma, Inc., a Delaware corporation (“Licensor”) and Laboratoires Mayoly Spindler SAS, a corporation created and organized under French laws (“Licensee”) (collectively, the “Parties” and each, a “Party”). Capitalized terms in this Agreement not otherwise defined will have the meaning set forth in Section 1.
ASSET PURCHASE AGREEMENTTermination Agreement • April 1st, 2019 • AzurRx BioPharma, Inc. • Pharmaceutical preparations • New York
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [*****], HAS BEEN OMITTED BECAUSE AZURRX BIOPHARMA, INC. HAS DETERMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO AZURRX BIOPHARMA, INC. IF PUBLICLY DISCLOSED.
